Human RBL1 adenoviral particles

The RBL1 gene, also known as retinoblastoma-like gene 1 or p107, encodes a key member of the retinoblastoma (RB) family of proteins and plays a key role in cell cycle regulation and tumor suppression. RBL1 acts as a transcriptional co-repressor that binds to the E2F transcription factor to repress the expression of genes required for cell cycle progression, particularly during the G1 phase. This regulatory mechanism ensures normal cell division and prevents uncontrolled proliferation, a hallmark of cancer. RBL1 is highly expressed in differentiated tissues and has overlapping but distinct functions from other RB family members, such as RB1 and RBL2 (p130). Furthermore, dysregulation of RBL1 has been implicated in a variety of cancers. Human RBL1 adenoviral particles are engineered viral vectors designed to efficiently deliver the RBL1 gene to target cells. Adenoviral vectors are widely used in molecular biology due to their high transduction efficiency, broad tropism, and ability to infect both dividing and non-dividing cells. These particles are replication-defective, which allows for stable transgene expression while ensuring safety. The researchers used human RBL1 adenoviral particles to study the role of this gene in cell cycle regulation, apoptosis, and tumor suppression, and to explore its potential therapeutic applications in cancer treatment.